These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 6797089)

  • 21. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.
    Chlopicki S; Olszanecki R; Marcinkiewicz E; Lomnicka M; Motterlini R
    Cardiovasc Res; 2006 Jul; 71(2):393-401. PubMed ID: 16713591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. gammaA/gamma' fibrinogen inhibits thrombin-induced platelet aggregation.
    Lovely RS; Rein CM; White TC; Jouihan SA; Boshkov LK; Bakke AC; McCarty OJ; Farrell DH
    Thromb Haemost; 2008 Nov; 100(5):837-46. PubMed ID: 18989528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of fibronectin, Von Willebrand factor, and fibrinogen in platelet interaction with solid substrata.
    Lahav J; Hynes RO
    J Supramol Struct Cell Biochem; 1981; 17(4):299-311. PubMed ID: 6977039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Repeat oral dosing of prasugrel, a novel P2Y12 receptor inhibitor, results in cumulative and potent antiplatelet and antithrombotic activity in several animal species.
    Niitsu Y; Sugidachi A; Ogawa T; Jakubowski JA; Hashimoto M; Isobe T; Otsuguro K; Asai F
    Eur J Pharmacol; 2008 Jan; 579(1-3):276-82. PubMed ID: 17996866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interactions of purified rat factor VIII/von Willebrand factor with rat and human platelets--effect of albumin and ristocetin.
    Dejana E; Furlan M; Barbieri B; Donati MB; Beck EA
    Thromb Haemost; 1984 Aug; 52(1):57-9. PubMed ID: 6437011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beta 3 integrin derived peptide 217-230 inhibits fibrinogen binding and platelet aggregation: significance of RGD sequences and fibrinogen A alpha-chain.
    Lasz EC; McLane MA; Trybulec M; Kowalska MA; Khan S; Budzynski AZ; Niewiarowski S
    Biochem Biophys Res Commun; 1993 Jan; 190(1):118-24. PubMed ID: 8422238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pretreatment of human platelets with plasmin inhibits responses to thrombin, but potentiates responses to low concentrations of aggregating agents, including the thrombin receptor activating peptide, SFLLRN.
    Kinlough-Rathbone RL; Perry DW; Rand ML; Packham MA
    Thromb Haemost; 1997 Apr; 77(4):741-7. PubMed ID: 9134653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ristocetin- and thrombin-induced platelet aggregation at physiological shear rates: differential roles for GPIb and GPIIb-IIIa receptor.
    Kasirer-Friede A; Frojmovic MM
    Thromb Haemost; 1998 Sep; 80(3):428-36. PubMed ID: 9759623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of pyridoxal 5'-phosphate (PALP) on human platelet aggregation, dense granule release and thromboxane B2 generation--role of Schiff base formation.
    Krishnamurthi S; Westwick J; Kakkar VV
    Thromb Haemost; 1982 Oct; 48(2):136-41. PubMed ID: 6891107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The physical exchange of factor VIII (FVIII) between von Willebrand factor and activated platelets and the effect of the FVIII B-domain on platelet binding.
    Li X; Gabriel DA
    Biochemistry; 1997 Sep; 36(35):10760-7. PubMed ID: 9271507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of ticlopidine administered to healthy volunteers on platelet function in whole blood.
    Heptinstall S; May JA; Glenn JR; Sanderson HM; Dickinson JP; Wilcox RG
    Thromb Haemost; 1995 Nov; 74(5):1310-5. PubMed ID: 8607115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies on fibronectin and its domains. I. Novel recombinant cell-binding domain of fibronectin--a modulator of human platelet functions.
    Vogel T; Werber MM; Guy R; Levanon A; Nimrod A; Legrand C; Gorecki M; Eldor A; Panet A
    Arch Biochem Biophys; 1993 Jan; 300(1):501-9. PubMed ID: 8424687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of ticlopidine of platelet function in men with stable angina pectoris.
    Berglund U; von Schenck H; Wallentin L
    Thromb Haemost; 1985 Dec; 54(4):808-12. PubMed ID: 3911481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo effect of ticlopidine on fibrinogen-platelet cofactor activity and binding of fibrinogen to platelets.
    Dunn FW; Soria J; Soria C; Thomaidis A; Lee H; Caen JP
    Agents Actions Suppl; 1984; 15():97-104. PubMed ID: 6091425
    [No Abstract]   [Full Text] [Related]  

  • 35. Adenosine diphosphate-induced aggregation of human platelets in flow through tubes: III. Shear and extrinsic fibrinogen-dependent effects.
    Goldsmith HL; Frojmovic MM; Braovac S; McIntosh F; Wong T
    Thromb Haemost; 1994 Jan; 71(1):78-90. PubMed ID: 8165650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet-dependent granulocyte activation in vitro: effect of ticlopidine.
    Laghi Pasini F; Ceccatelli L; Pasqui AL; Orrico A; Capecchi PL; Di Perri T
    Int J Tissue React; 1985; 7(5):367-72. PubMed ID: 2997067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decrease of platelet intracellular pH and adhesion by ticlopidine in patients with vascular disease.
    Lechi C; Gaino S; Andrioli G; Paluani F; Guzzo P; Bellavite P; Zatti M; Arosio E
    Int Angiol; 1998 Mar; 17(1):38-42. PubMed ID: 9657246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship of ADP-induced fibrinogen binding to platelet shape change and aggregation elucidated by use of colchicine and cytochalasin B.
    Peerschke EI; Zucker MB
    Thromb Haemost; 1980 Feb; 43(1):58-60. PubMed ID: 7404479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ticlopidine facilitates the deaggregation of human platelets aggregated by thrombin.
    Cattaneo M; Akkawat B; Kinlough-Rathbone RL; Packham MA; Cimminiello C; Mannucci PM
    Thromb Haemost; 1994 Jan; 71(1):91-4. PubMed ID: 8165651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet activation induced by a human neuroblastoma tumor cell line is reduced by prior administration of ticlopidine.
    Bastida E; Escolar G; Almirall L; Ordinas A
    Thromb Haemost; 1986 Jun; 55(3):333-7. PubMed ID: 3750263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.